APA (7th ed.) Citation

Berger, A. A., Robinson, C., Winnick, A., Izygon, J., Jacob, B. M., Noonan, M. J., . . . Urits, I. (2022). Opicapone for the Treatment of Parkinson's Disease "Off" Episodes: Pharmacology and Clinical Considerations. Clinical Drug Investigation, 42(2), 127. https://doi.org/10.1007/s40261-021-01109-3

Chicago Style (17th ed.) Citation

Berger, Amnon A., et al. "Opicapone for the Treatment of Parkinson's Disease "Off" Episodes: Pharmacology and Clinical Considerations." Clinical Drug Investigation 42, no. 2 (2022): 127. https://doi.org/10.1007/s40261-021-01109-3.

MLA (9th ed.) Citation

Berger, Amnon A., et al. "Opicapone for the Treatment of Parkinson's Disease "Off" Episodes: Pharmacology and Clinical Considerations." Clinical Drug Investigation, vol. 42, no. 2, 2022, p. 127, https://doi.org/10.1007/s40261-021-01109-3.